OTC · Drug Manufacturers - Specialty & Generic

CBD Life Sciences Inc. (CBDL) Stock

$0.00 OTC: CBDL Healthcare

CBD Life Sciences Inc. specializes in formulating and distributing a broad array of organic items infused with cannabidiol.

Valuation

MetricValue
Price$0.00
Market Cap$375394
P/E Ratio-29.85
P/B Ratio0.38
P/S Ratio12.07
EPS (TTM)$0.00
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-8.71%
ROA-10.81%
ROCE-11.20%
Gross Margin42.20%
Operating Margin-94.93%
Net Margin-49.76%
Debt/Equity0.00
Current Ratio15.12

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-5.0M$-1.0M$0$-1.0M$0
Net Profit$-5.0M$-1.0M$0$-1.0M$0
EPS$0.00$0.00$0.00$0.00$0.00
Op Margin-8654.2%-536.6%-47.0%-695.4%-103.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.0M$0$0$0$1.0M
Total Liabilities$0$0$0$0$0
Cash$1.0M$0$0$0$0
Borrowings$0$0$0$0$0

Latest News

CBD Life Sciences Inc. (CBDL) Announces Launch of CBD Flavored Vapes ACCESS Newswire · May 12, 2026 CBD Life Sciences Inc. (CBDL) Announces Launch of CBD Pouches Nicotine Free ACCESS Newswire · May 5, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-5.0M$-1.0M$0$-1.0M$0
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$1.0M$-1.0M$0$0$0
Free Cash Flow$-5.0M$-1.0M$0$-1.0M$0

Valuation & Return Ratios

MetricValue
PEG Ratio-0.30
EV / EBITDA-0.69
FCF Yield20.81%
Quick Ratio14.21
Interest Coverage0.00
Return 1Y0.00%
Return 3Y-99.33%
Return 5Y-99.83%

Ownership

Insiders Held0.00%
Institutions Held0.00%
Institutions Float Held0.00%
Institutional HolderSharesReport Date
Ifp Advisors, Inc295,0002021-12-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AOXGAoxing Pharmaceutical Company, Inc. $0.00 — -86.98 $266756 0.00%
ETBIEastgate Biotech Corp. $0.00 — -1.58 $6.17M 0.00%
GPFTGrapefruit USA, Inc. $0.00 — 0.17 $71740 0.00%
HPMMHemp Naturals, Inc. $0.00 — 0.00 $26426 0.00%
IVIXFInvion Limited $0.04 +0.00% -0.31 $4.03M 0.00%

About CBD Life Sciences Inc.

CBD Life Sciences Inc. specializes in formulating and distributing a broad array of organic items infused with cannabidiol. Their extensive range of natural CBD offerings includes hemp tinctures, topical massage oils, targeted recovery and pain relief balms, dietary aids to support anxiety and restful sleep, various consumable treats, and a dedicated collection of products for animal companions. The company's principal operations are conducted from Scottsdale, Arizona.

CBD Life Sciences Inc. (CBDL) stock trades at $0.00 with a market capitalization of $375394. The stock is valued at a price-to-earnings (P/E) ratio of -29.85, price-to-book of 0.38, price-to-sales of 12.07. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, CBD Life Sciences Inc. generates a return on equity (ROE) of -8.71%, return on capital employed of -11.20%, an operating margin of -94.93%, a net profit margin of -49.76%.

Official website: www.thecbdvault.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides